Literature DB >> 6383601

Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. II. Identification of the cellular target structures by immunoprecipitation and SDS-PAGE analysis.

S Paulie, H Koho, H Ben-Aissa, Y Hansson, M L Lundblad, P Perlmann.   

Abstract

The cellular target structures for six monoclonal antibodies raised against cultured human bladder carcinoma cells (TCC) were investigated. The specificities of these antibodies when tested against a large panel of cells have been described in the companion paper. Radiolabeled cell lysates were precipitated with the different monoclonal antibodies bound to protein A (Staphylococcus aureus) on a matrix of Sepharose beads. The precipitates were separated by sodium dodecyl sulfate- gel electrophoresis (SDS-PAGE) and analyzed by autoradiography. The antibodies 4B5, 7E9, and 14B11 have previously been found to react in a similar way with TCC-targets and some non-TCC tumor cells, but not with normal urothelial cells or cells of hematopoietic origin. When tested with lysates of a TCC-cell line (TCCSuP) a strong 92K band and a weak 23K band were precipitated with any one of these antibodies. These polypeptides were expressed on the cell surface and were not linked by disulfide bonds. Depletion experiments confirmed that the three antibodies recognized the same antigens. Another antibody (4E8) probably directed to a differentiation antigen present on both urothelial and melanoma cells detected two high molecular polypeptides, 190K and 170K. Antibodies from the S2C6 hybridoma, which displayed a distinct dual specificity for TCC- targets and for malignant or transformed cells of B cell origin, precipitated a 50K component from extracts of either TCC- or B cell-derived cell lines. Antibodies produced by the S2A9 hybridoma were shown to bind to a framework epitope of the HLA-A, B, C heavy chain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6383601     DOI: 10.1007/bf00205482

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  25 in total

1.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses.

Authors:  C J Der; T G Krontiris; G M Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

4.  Human melanoma-associated antigen p97 is structurally and functionally related to transferrin.

Authors:  J P Brown; R M Hewick; I Hellström; K E Hellström; R F Doolittle; W J Dreyer
Journal:  Nature       Date:  1982-03-11       Impact factor: 49.962

5.  Characteristics of isolated erythrocyte complement receptor type one (CR1, C4b-C3b receptor) and CR1-specific antibodies.

Authors:  N J Dobson; J D Lambris; G D Ross
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

6.  Humoral and cellular immune reactions against tumor cells in patients with urinary bladder carcinoma. Correlation between direct and antibody-dependent cell-mediated cytotoxicity.

Authors:  Y Hansson; S Paulie; A Larsson; M L Lundblad; P Perlmann; I Näslund
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

7.  Quantitative analysis of melanoma-associated antigen p97 in normal and neoplastic tissues.

Authors:  J P Brown; R G Woodbury; C E Hart; I Hellström; K E Hellström
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

8.  Cell surface antigens of human bladder cancer defined by mouse monoclonal antibodies.

Authors:  Y Fradet; C Cordon-Cardo; T Thomson; M E Daly; W F Whitmore; K O Lloyd; M R Melamed; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

9.  A monoclonal antibody-enzyme immunoassay for serum carcinoembryonic antigen with increased specificity for carcinomas.

Authors:  A Hedin; L Carlsson; A Berglund; S Hammarström
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

10.  Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody.

Authors:  J D Lambris; N J Dobson; G D Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

View more
  12 in total

1.  Short-circuiting long-lived humoral immunity by the heightened engagement of CD40.

Authors:  Loren D Erickson; Brigit G Durell; Laura A Vogel; Brian P O'Connor; Marilia Cascalho; Teruhito Yasui; Hitoshi Kikutani; Randolph J Noelle
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

2.  Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Guérin.

Authors:  A P van der Meijden; P A Steerenberg; I M van Hoogstraaten; J A Kerckhaert; L M Schreinemachers; E J Harthoorn-Lasthuizen; A M Hagenaars; W H de Jong; F M Debruijne; E J Ruitenberg
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

3.  Parallel pattern of expression of CD43 and of LFA-1 on the CD45RA+ (naive) and CD45RO+ (memory) subsets of human CD4+ and CD8+ cells. Correlation with the aggregative response of the cells to CD43 monoclonal antibodies.

Authors:  R Youseffi-Etemad; B Axelsson
Journal:  Immunology       Date:  1996-03       Impact factor: 7.397

4.  Polymorphic expression of a human superficial bladder tumor antigen defined by mouse monoclonal antibodies.

Authors:  Y Fradet; N Islam; L Boucher; C Parent-Vaugeois; M Tardif
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

5.  Engineered Fc variant antibodies with enhanced ability to recruit complement and mediate effector functions.

Authors:  Gregory L Moore; Hsing Chen; Sher Karki; Greg A Lazar
Journal:  MAbs       Date:  2010 Mar-Apr       Impact factor: 5.857

6.  Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence.

Authors:  H Koho; S Paulie; H Ben-Aissa; I Jónsdóttir; Y Hansson; M L Lundblad; P Perlmann
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes.

Authors:  S Paulie; B Ehlin-Henriksson; H Mellstedt; H Koho; H Ben-Aissa; P Perlmann
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

Review 8.  CD40/CD40 ligand interactions in immune responses and pulmonary immunity.

Authors:  Tsutomu Kawabe; Miyoko Matsushima; Naozumi Hashimoto; Kazuyoshi Imaizumi; Yoshinori Hasegawa
Journal:  Nagoya J Med Sci       Date:  2011-08       Impact factor: 1.131

9.  Specificities and binding properties of 2 monoclonal antibodies against carcinoma cells of the human urinary bladder.

Authors:  H Ben-Aissa; S Paulie; H Koho; P Biberfeld; Y Hansson; M L Lundblad; H Gustafson; I Jonsdottir; P Perlmann
Journal:  Br J Cancer       Date:  1985-07       Impact factor: 7.640

Review 10.  The Contribution of CD40/CD40L Axis in Inflammatory Bowel Disease: An Update.

Authors:  Nezha Senhaji; Kevin Kojok; Youssef Darif; Christophe Fadainia; Younes Zaid
Journal:  Front Immunol       Date:  2015-10-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.